New mRNA flu shots enter human testing
NCT ID NCT07121192
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 27 times
Summary
This study tests new mRNA-based seasonal flu vaccines in 776 healthy adults aged 18 and older. The goal is to see how well the vaccines trigger an immune response and whether they are safe. Participants will be monitored for side effects like pain, fever, and fatigue. The vaccines are made by GlaxoSmithKline and aim to protect against multiple flu strains.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLUENZA, HUMAN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
GSK Investigational Site
Anniston, Alabama, 36207, United States
-
GSK Investigational Site
Fair Oaks, California, 95628, United States
-
GSK Investigational Site
San Diego, California, 92120, United States
-
GSK Investigational Site
San Diego, California, 92123, United States
-
GSK Investigational Site
Walnut Creek, California, 94598, United States
-
GSK Investigational Site
Hialeah, Florida, 33012, United States
-
GSK Investigational Site
Jupiter, Florida, 33458, United States
-
GSK Investigational Site
Miami, Florida, 33186, United States
-
GSK Investigational Site
Atlanta, Georgia, 30281, United States
-
GSK Investigational Site
Valparaiso, Indiana, 46383, United States
-
GSK Investigational Site
Lenexa, Kansas, 66219, United States
-
GSK Investigational Site
Springfield, Massachusetts, 01103, United States
-
GSK Investigational Site
Carson City, Nevada, 89706, United States
-
GSK Investigational Site
Rochester, New York, 14609, United States
-
GSK Investigational Site
Greensboro, North Carolina, 27408, United States
-
GSK Investigational Site
Cleveland, Ohio, 44122, United States
-
GSK Investigational Site
North Charleston, South Carolina, 29405, United States
-
GSK Investigational Site
Austin, Texas, 78705, United States
-
GSK Investigational Site
DeSoto, Texas, 75115, United States
-
GSK Investigational Site
Fort Worth, Texas, 76135, United States
-
GSK Investigational Site
Newport News, Virginia, 23606, United States
-
GSK Investigational Site
Seattle, Washington, 98104, United States
Conditions
Explore the condition pages connected to this study.